Quick Takeaways
- Daron Evans has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,761,931.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Daron Evans
- Location
- South Orange, NJ
- Summary
- The estimated net worth of Daron Evans is at least $1,761,931 dollars as of 31 Mar 2026. Daron Evans is the CFO of Rezolute, Inc. and owns shares of Rezolute, Inc. (RZLT) stock worth about $1.41M. Daron Evans is the CEO Specialty Renal Products of NEPHROS INC and owns shares of NEPHROS INC (NEPH) stock worth about $351.8K.
- Signature
- /s/ Daron Evans
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Daron Evans and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Rezolute, Inc. ($1,410,136).
- Past-year value change for that position: +$181,494.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Daron Evans
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | Cfo | $1,410,136 | +$181,494 | +15% | 30 Mar 2026 |
| NEPH | NEPHROS INC | CEO Specialty Renal Products | $351,795 | 24 May 2021 |
Insider Transactions Reported by Daron Evans:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.